Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Gene Expression Market Size And Revenue Outlook Through 2030
The gene expression market has seen rapid expansion in recent years. It is projected to increase from $12.67 billion in 2025 to $14.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. This historical growth can be attributed to several factors, including the increase in academic genomics research funding, the growing prevalence of chronic and genetic diseases, the early adoption of microarray technologies, the expansion of pharmaceutical R&D pipelines, and the rising utilization of PCR-based techniques.
The gene expression market is projected to experience substantial growth over the coming years. Its valuation is anticipated to reach $22.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.9%. This growth during the projected period can be ascribed to advancements in RNA sequencing technologies, a heightened emphasis on precision medicine, expansion in clinical diagnostics applications, the incorporation of AI into gene expression data analysis, and increased investments within the biotechnology industry. Key trends expected over the forecast horizon encompass the broadening of single-cell gene expression analysis, enhanced utilization of spatial transcriptomics, an increasing need for high-throughput PCR platforms, the growing acceptance of multi-omics integration, and the establishment of standardized gene expression workflows.
Get A Free Sample Report With In-Depth Market Insights:
Gene Expression Market Growth Backed By Core Demand Fundamentals
The future expansion of the gene expression market is anticipated to be propelled by the increasing prevalence of chronic diseases. These are defined as long-term medical conditions that persist for an extended duration, typically three months or more. Gene expression analysis is instrumental in chronic diseases for deciphering the underlying molecular mechanisms, pinpointing potential biomarkers, and developing targeted therapeutic approaches. For example, as reported in June 2024 by the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This figure marked an 18% increase from the 3,065,825 cases observed in 2022. Thus, the growing incidence of chronic diseases will be a significant driver for the gene expression market’s growth.
Gene Expression Market Segment Analysis Spotlighting Growth Areas
The gene expression market covered in this report is segmented –
1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products
2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation
3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis
4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications
Subsegments:
1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents
2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays
3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables
Gene Expression Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the gene expression market are concentrating on developing innovative products, such as gene detection assays, to achieve a competitive advantage and increase their revenue. A gene detection assay within gene expression refers to a method for identifying and quantifying genetic molecules, offering insights into the activity and abundance of specific genes. For instance, in January 2023, Bio-Techne Corporation, a US-based biotech company specializing in research instruments, expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by introducing the RNAscope Plus smRNA-RNA detection assay. This new assay enables the simultaneous fluorescent detection of a small regulatory RNA alongside three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution. Designed to accommodate large studies, the assay is compatible with the Leica Bond Rx platform and is available as a manual assay for convenient use. These therapeutic nucleic acids hold the potential to modulate the expression and functionality of specific target genes, thereby facilitating the creation of customized treatments for inherited or acquired diseases that have proven resistant to conventional therapies.
Gene Expression Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation
View The Full Gene Expression Market Report:
Gene Expression Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model